Introduction
============

Environmental enteropathy (EE) and environmental enteric dysfunction (EED) are terms used to describe the same pathophysiological, subclinical condition of reduced small intestinal barrier and absorptive function that has high prevalence among children living in low- to middle-income countries where poor hygiene, inadequate sanitation, and malnutrition pervade ([@r9]; [@r24]). The spectrum of EED involves structural and functional changes to the gastrointestinal tract (GI) that may include, but not be limited to, altered villous architecture, impaired mucosal immunity, nutrient malabsorption, and growth faltering ([@r27]; [@r29]). Chronic enteric pathogen exposures, including asymptomatic infections, and intestinal permeability in young children have thus far been central to EED research ([@r51]). However, we suggest that we explore the possible role for diversity of environmental toxicant exposures as well as dysbiosis of the gut microbiome from birth to 2 years of age to address major gaps in our knowledge of EED. The host burden and the host responses to toxicant exposures are highlighted in the concept of an "enteric dysfunction exposome" ([@r58]). Across global geography and age groups, EED may be influenced in ways that have not yet been connected to existing knowledge of toxicologic importance, and this commentary highlights the compelling case for xenobiotics to be investigated in EED etiology. The enteric dysfunction exposome would not be limited to enteric pathogens and mycotoxins, but would encompass chemical classes for a wide range of environmental toxicants \[i.e., endocrine disruptors, trace heavy metals, persistent organic pollutants (POPs), volatile organic chemicals (VOCs), and behaviors\] ([@r37]). The presence of chemical exposures in maternal blood and breast milk may affect infant immune tolerance, gut microbiome colonization, small intestinal development, and nutrient availability and absorption during *in utero*, prenatal, and postnatal periods; yet these combination of factors remain poorly characterized in EED-endemic regions ([@r9]; [@r17]; [@r48]; [@r58]). Thus, EED evaluation should include xenobiotic exposures that can be monitored noninvasively through blood, urine, saliva, and/or stool using both nontargeted omics-based and targeted measurements of exogenous and endogenous small molecules ([@r23]). This approach exhibits strong potential to not only identify a suite of reliable EED exposure biomarkers but also design interventions that can perturb an EED-susceptible exposome ([@r46]; [@r49]; [@r58]).

Studies in Bangladesh ([@r27]), Brazil ([@r14]), The Gambia ([@r7], [@r6]), Nepal ([@r26]), Malawi ([@r1]; [@r16]), and Tanzania ([@r36]) demonstrate that EED is widespread and pervasive. The current list of EED-associated morbidities provides a strong rationale for identifying biomarkers, diagnostics, preventive agents, and sustainable treatment solutions ([@r23]). Along with prevalent severe acute malnutrition-- and undernutrition-related childhood mortalities, stunting is postulated to be secondary to EED ([@r24]), with EED being a possible contributor to multiple generations of the 171 million children being affected by stunting globally ([@r12]). In a case--control study of 202 stunted Zimbabwean infants, a measurement of the biomarkers of intestinal inflammation revealed that exposure to low-grade, chronic inflammation *in utero* and during early postnatal phases of life was associated with stunting that was likely due to extensive enteropathy that occurs during infancy ([@r45]). We suggest that the milieu of EED causative agents, epigenetic, and genetic factors merit elucidation in order to fill the gap in our knowledge regarding when and how EED can be controlled or prevented. Thus, we can hypothesize that multiple layers of environmental, microbiological, pharmacological, and dietary interventions are needed to reasonably reduce EED prevalence. Identification of EED biomarkers is the subject of ongoing global health research, and as such opens opportunities for new diagnostics and therapeutics ([@r34]; [@r43]). The nature of EED research in children of developing countries merits inclusion of the spectrum of host--microbe interactions and chemical exposure diversity; investigating the combined effect could advance EED risk assessment, improve EED diagnostics and therapeutics, and deploy EED prevention initiatives.

EED Characteristics, Etiology, and Epidemiology
===============================================

EED is a subclinical disorder characterized by abnormal morphology and physiology of the small bowel; specifically, it features increased gut permeability, altered gut villous architecture and function, nutrient malabsorption, and growth faltering ([@r27]; [@r29]; [@r44]). Gastrointestinal tissue biopsies of children with EED display crypt hyperplasia, villous atrophy, lymphocyte infiltration into the lamina propria and epithelium, and reduced mucosal surface area ([@r27]). The biopsies are also characterized by T-cell activation and heightened Th1 (T helper cell 1) cellular immune responses similar to what is seen in celiac sprue. This is not consistent with allergic responses, but rather appears to be a response to specific pathogens, presumably from ingestion of food and water containing fecal contaminants ([@r7]). The intestinal epithelium creates a physical barrier between the external and internal environments in which the intracellular tight junctions and the apical brush borders prevent microbial attachment and invasion ([@r52]). EED develops and occurs in the absence of overt manifestation of diarrhea; it was originally referred to as tropical enteropathy in the 1970s when a moderate number of documented cases of abnormal jejunal biopsies were identified from persons in tropical regions ([@r29]). Intestinal pathology varied geographically, and the condition resolved when affected individuals migrated to developed regions ([@r28]). Subsequent studies in varied populations around the world showed that tropical enteropathy did in fact exist throughout the tropics, but that it was also absent in some tropical populations of high socioeconomic status, such as Qatar and Singapore. This illuminated the premise that environmental conditions were critical drivers of the condition, instead of geographical position ([@r44]). We believe that the unsanitary conditions in which EED-affected individuals reside contribute to the overriding causal factors of EED. However, we postulate that multiple sources of exposures contribute to both the transient and chronic/persistent nature of EED ([Figure 1](#f1){ref-type="fig"}). In addition to poor sanitation, dietary contaminants and environmental toxicants can be equally hazardous or exert additive and or synergistic effects on the developing gastrointestinal tract via the microbiome, and thus merit qualitative and quantitative assessments for contributions to EED ([@r4]; [@r11]; [@r63]). Although EED has been shown to be reversible if acquired in adulthood, as in the adult Peace Corps volunteers study ([@r29]), adults who resided in impoverished areas throughout their lifetimes demonstrate that EED acquired in childhood is chronic and difficult to reverse even after relocating to clean environments ([@r22]; [@r24]). For example, in a longitudinal cohort study of healthy African adults in Zambia, endoscopic biopsies of the proximal jejunem were obtained serially over 3 years to assess for changes in mucosal architecture in response to environmental conditions. At baseline and over the duration of the study, the entire cohort revealed the absence of predominant finger-like villi---an abnormal biopsy finding representative of EED---even though these adults were "healthy" and asymptomatic of intestinal infection ([@r22]).

![Environmental exposures that contribute to transient or chronic/persistent EED: (*A*) conventional factors thought to be responsible for EED; (*B*) dietary exposure factors known to influence the gut microbiota ecology; (*C*) environmental toxicants with potential to affect intestinal function and physiology. Dietary exposure and environmental toxicants are emerging factors that can be included in EED associated biomarker identification studies. This classification can help determine the drivers of transient or chronic EED states.](ehp.1510459.g001){#f1}

Microbial and Dietary Origins of EED
====================================

Metagenomic studies of infant and childhood stool samples show that early postnatal environmental exposures have a pivotal role in shaping the predominant phylogenic structure of gut microbiota, and that this microbial configuration occurs rapidly during the first 2 years of life ([@r21]; [@r25]). A recent Global Enteric Multicenter Study (GEMS) of diarrhea in young children in Mali, The Gambia, Kenya, and Bangladesh reported that during the first year of life, a healthy infant gut microbiota is characterized by a comparatively low diversity as well as a relatively high proportion of facultative anaerobes, and potentially pathogenic organisms that are believed to play a role in the development of host immune system. A high-throughput 16S rRNA gene sequencing was used to compare fecal microbiota composition in 992 children \< 5 years of age who had been diagnosed with moderate to severe diarrhea with the microbiota from diarrhea-free controls subjects ([@r41]). Predominant bacteria vary among different populations of children, possibly in relation to diet ([@r11]; [@r41]; [@r61]; [@r62]). According to [@r55], gut microbiota immaturity was defined by relative microbiota diversity and microbiota-for-age *z*-score indices. In addition to detecting limited changes in a group of malnourished children split into two dietary treatments, they reported reduced bacterial diversity with detection of 220 significantly different operational taxonomic units, 165 of which had diminished proportional representation in the stool microbiota of severely malnourished children compared with healthy children ([@r55]). Thus, the possible role for an immature gut microbiota associated with low-dose toxicant exposures in EED merits continued investigation ([@r18]; [@r55]) because the acquisition and composition of gut microbiota has also shown dependence on many factors including region of birth, history of hospitalization, mode of delivery, infant weaning, diet, age, sex, presence of siblings, infections, and antibiotic use ([@r37]; [@r46]; [@r58]; [@r62]). It is plausible that EED may cause zinc deficiency by reducing its absorption, yet enteric infections can impair zinc homeostasis, increase deficiency, and aggravate EED by weakening gut barrier functions, which elevates incidences of GI tract infection and inflammation as a result of decreased gut absorptive capacity ([@r30]). Chronic parasitic infections with *Ascaris*, hookworms, and *Trichuris* may trigger or perpetuate EED via multiple inflammatory pathways ([@r3]).

Understanding EED as a congregation of changes in small-intestine function can help prevent malnutrition and stunting in infants in developing countries ([@r24]). EED development has been associated with unrestrained enteric T-cell activation by persistent and abnormal concentrations of ingested fecal bacteria in the small intestinal lumen ([@r19]). During nutrient processing, commensal bacteria secrete antimicrobial compounds that prevent infections by pathogenic microbes, and commensals support immune system functions to achieve homeostasis ([@r8]). It has been proposed that disruption of the gut homeostatic balance in children living in pathogen-laden environments supports low-grade chronic immune system stimulation that can culminate into small intestine--function impairment ([@r39]). We propose that chemical toxicant exposures merit investigation alongside these pathogens as contributors to low-grade chronic immune stimulation.

The Exposome
============

Applying an exposome lens to enhance the current understanding of EED may have advantages given the strong evidence already linking dietary exposures, malnutrition, immature gut microbiota, and diarrheal disease--causing pathogens ([@r51]). The exposome is defined as "the cumulative measure of environmental influences and associated biological responses throughout the lifespan, including exposures from the environment, diet, and behavior" ([@r37]). The exposome includes relevant exposures from food, breast milk, water, air and soil, as well as microbes (e.g., bacteria, fungus, yeasts, archaea), toxicants, and food allergens ([@r31]). By evaluating the entire exposome in relation to EED, we may identify missing links in the multiple causative factors that contribute to EED. The exposome integrates overlapping domains of general and specific external factors along with the internal environment of the host ([@r8]). The exposome seeks to enumerate all of the possible sources of exposure and integrate biological data ([@r31]; [@r47]), and would incorporate a more holistic picture of environmental exposures to EED epidemiological studies.

Chemical toxicants and gut microbiome studies have revealed meaningful interactions. For example, nonabsorbed heavy metals have a direct impact on the gut microbiota ([@r4]). We postulate that dietary exposure from breast milk, food, and water to multiple classes of pesticides might be a major contributor to EED. Children are uniquely sensitive to toxic chemicals in the environment, with greater concentrations of exposure to toxicants with respect to their body weight. More studies are needed to understand the interaction between the gut microbiome and xenobiotics in EED-prone regions given that xenobiotics affect physiology, metabolism, and gene expression of the human gut microbiome ([@r33]).

Mycotoxins are common contaminants in foods such as maize, oats, rye, barley, wheat, and peanuts. An impaired intestinal integrity similar to EED has been demonstrated in animal model experiments following aflatoxin poisoning ([@r44]). Aflatoxin, fumonisin, and deoxynivalenol may have similar EED characteristics by which they impair the gut to induce stunting ([@r53]). These mycotoxins may also share a convergent pathway resulting in mucosal changes seen in EED ([@r53]). Specifically, it has been proposed that aflatoxins may affect child growth by collectively reducing zinc bioavailability, impairing protein synthesis and nutrient metabolism, and damaging the enterocytes. Sequential insults by these mycotoxins in combination with chemical toxicants may affect children at their most vulnerable developmental stages and serially interrupt critical developmental milestones ([@r3]).

The gut microbiome is central to growth and nutritional status through nutrient transformation as well as immune system and metabolic signaling ([@r20]). A diminished mucosal surface area and damage to the epithelium may impede nutrient absorption and lead to malnutrition. For instance, aberrations in the gut microbiome have been implicated as casual factors in Kwashiorkor, a form of severe acute malnutrition resulting from inadequate nutrient intake in addition to environmental factors ([@r54]). Early-life functional changes in the GI tract may herald and be exacerbated by a myriad of malnutrition drivers including inadequate diet, poverty, food insecurity, and infection with enteric pathogens, culminating in stunting ([@r23]).

The microbiome produces many metabolites that greatly influence host response, as seen in vitamin and amino acid nutrient processing during infancy ([@r62]). Related faulty nutrient processing has been implicated in malnutrition, which subsequently increases susceptibility to infectious diseases ([@r13]). Research shows that dietary habits shape nutrigenomics in an evolutionary fashion via influences from human genetics and gut microbiota ([@r10]), and that systematic changes in dietary habits can lead to changes in the microbiota, functionally affecting the host nutrition status and immune responses ([@r21]). For instance, children from The Gambia display growth-faltering patterns characteristic of resource poor countries, as shown by evidence of cell-mediated enteropathy across a range of nutritional states ([@r7]). Despite focused nutrition interventions (e.g., zinc and iron supplementation), growth faltering continues, prompting the need to investigate other EED causal factors.

Exposome Perspectives for EED and Stunting
==========================================

Children susceptible to undernutrition suffer from a vicious cycle of diseases, malnutrition, and stunting in low- and middle-income countries ([@r24]). Given the effects of the microbiome and microbiota on growth and development, there is need to determine the effect of both environmental chemicals on microbes and microbe modifications to environmental chemicals. Our knowledge of the metabolome should be integrated with the gut microbiota of children, both healthy and stunted, in EED-endemic regions to determine the relationship between host-, microbe-, and diet-derived metabolites and EED ([@r5]; [@r50]; [@r54]; [@r55]). Examining the combined effect of environmental exposures and nutrition in EED animal models and children with EED may also give insights into the basic characteristics of an EED microbiome. Improved understanding of the impact of a child's early-life exposome on health is important in the diagnosis, treatment, and prevention of EED ([@r8]). Investigation of the human microbiome, proteome, and metabolome opens up new frontiers for EED research, and these approaches should be fully used to characterize exposure biomarkers in infancy and childhood. Many studies attempt to show the role of microbes or microbial effects on EED development ([@r9]; [@r24]), further stimulating discussions about the responsible causal agents. The gut microbiota varies widely among individuals and geographical locations; this may be attributable to exposome variation in dietary patterns, pathogens, pesticides, drugs, and environmental pollutants. Use of microbial population genetics and metabolomics to describe EED phenotypes across regions is a promising integrative systems biology approach to help discover unknown causes of EED with respect to environmental exposures. For instance, gnotobiotic mice have been used to test the effect of diet, environmental chemicals and toxicants on the gut microbiota and host gastrointestinal physiology ([@r55]; [@r56]).

The chronic nature of EED can exacerbate persistent malnutrition and micronutrient deficiencies; hence, there is need to search for new targets for nutritional interventions ([@r35]). Children in the first 2 years of life have a high likelihood of stunting because of suboptimal breast and complementary feeding practices, micronutrient deficiencies ([@r2]), poor sanitation and recurrent infections, exposures from mycotoxins, heavy metals, and chemical pollutants ([@r42]) as well as exposure to organic pesticides, as demonstrated by the presence of their residues in breast milk ([@r38]; [@r64]). The child's ability to reverse the risk of stunting may be further reduced if intervention does not take place in the first 2 years of life, a critical period ([@r2]), especially if the environment remains resource constrained or food insecure ([@r32]; [@r42]; [@r57]). This critical window was demonstrated in a study of healthy Zimbabwe infants where critical periods of poor linear growth were associated with low-grade chronic inflammation ([@r45]). In addition, specific pathogens or chemical toxicants may aggravate stunting via chronic infections, inflammation, and or gut mucosal damage ([@r20]).

Nutritional rehabilitation of severely or moderately malnourished children in low-income countries should be accompanied by a clear understanding of the impact of diet and environmental toxicants on the overall nutrition profile and growth and development parameters. There are limited data about the adverse health effects associated with exposure to multiple environmental sources, so there is need to examine the toxicological effects on the developing GI mucosa and immune systems resulting from cumulative exposures to environmental contaminants ([@r40]). Geographic information systems (GIS) mapping may be a useful tool in examining the spatial distribution of the exposome in conjunction with other measures. Specifically, EED has been observed alongside stunting in The Gambia, Guatemala, Bangladesh, and Malawi ([@r9]). Using these selected EED research regions, we created a simplified GIS map ([Figure 2](#f2){ref-type="fig"}) to demonstrate how variables such as stunting, chemical exposures, and zinc deficiency illustrate the rationale for further investigation of an EED exposome. Given that the prevalence of low height-for-age (stunting) in children \< 5 years old has been recommended as an indirect indicator of a population's risk for zinc deficiency ([@r59]), additional exposures and exposome factors could also be geospatially mapped in this context. Correlations between the exposome and EED may lead to novel insights of high relevance to environmental health. With a better understanding of the biomarkers of chemical exposure and EED, we envision a future scenario under which EED can be prevented and treated using multiple approaches that will include a clean living environment, hygiene, better nutrition, and perhaps restored, mature homeostatic gut microbial ecosystems that do not result in growth stunting.

![Observations of stunting, obsolete chemical stockpiles, and zinc deficiency in five environmental enteric dysfunction research regions: Guatemala, Malawi, The Gambia, Bangladesh, and Nepal. This simplified GIS map shows two variables from the exposome---chemical pesticides and zinc deficiency---and associations in known EED-affected countries alongside stunting. Data source for stunting: [@r60]. Data source for obsolete chemical stockpiles: [@r15]. Data source for zinc deficiency: [@r59].](ehp.1510459.g002){#f2}

Conclusions and Future Research Needs
=====================================

The exposome includes a broad spectrum of possible factors that may be involved in EED. This concept offers a novel perspective for chemical toxicants' roles in disrupting microbiota maturity, because chemical toxicants are embedded in the microbial ecosystem and affect how the gut and immune system develop in the first few years of life. Chemical exposures may play a crucial role in early-childhood growth and development via multiple mechanisms, and merit inclusion in EED studies across geographically diverse regions. Integration of serum metabolomics and proteomics could reveal an EED-associated exposome across developing nations that could lead to novel and promising approaches to identify, validate, and differentiate EED globally. Mechanistic connections among chemical toxicant exposures, immunity, and the gut microbiota ecosystem during growth and development may guide future EED therapeutic studies to alleviate stunting. A compelling reason for embracing the exposome in EED is the potential for bi-directional relationships to emerge between biomarkers of exposure and biomarkers of disease, as well as to identify innovative combinations of preventive and therapeutic approaches that can sustainably reduce EED prevalence globally.
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